Villemont A-S, Kocaba V, Janin-Manificat H, Abouaf L, Poli M, Marty A-S, Rabilloud M, Fleury J, Burillon C
Service d'ophtalmologie, hôpital Edouard-Herriot, 69003 Lyon, France; Université Claude-Bernard Lyon 1, 69100 Villeurbanne, France.
Service d'ophtalmologie, hôpital Edouard-Herriot, 69003 Lyon, France; Université Claude-Bernard Lyon 1, 69100 Villeurbanne, France.
J Fr Ophtalmol. 2017 Sep;40(7):592-605. doi: 10.1016/j.jfo.2017.03.004. Epub 2017 Aug 10.
To evaluate the long-term outcomes of artificial iris intraocular lenses sutured to the sclera for managing traumatic aphakia and aniridia.
All consecutive cases receiving a Morcher combination implant from June 2008 to February 2016 in Edouard-Herriot Hospital (Lyon, France) were included in this single-center retrospective study. Visual acuity, subjective degree of glare, quality of life and surgical complications were evaluated.
Seventeen eyes of 17 patients were included, among which 82% were male. The mean age was 42 years. The injuries consisted of 23.5% contusion and 70.5% open globe injuries, of which 41% were globe ruptures. There was one postoperative case. A penetrating keratoplasty was performed at the same time for eight eyes. The mean follow-up was 32 months. Best-corrected visual acuity improved in 41.2%, remained the same in 17.6% and decreased in 41.2% of our cases. Distance vision averaged 1±0.25 line better and near vision 2.2±0.32 lines better when visual acuity was quantifiable before surgery. Glare improved in 80% of patients and remained stable in 20%, decreasing on average from 3.3/5 [min. 3-max. 4; SD: 0.48] before surgery to 1.9/5 [min. 0-max. 4; SD: 1.197] after surgery. Regarding the esthetic results, 78% of the patients declared themselves reasonably to very satisfied; 57% reported no limitation of activities of daily living, and 43% reported mild limitation. Ocular hypertension and glaucoma, found in 40% of eyes, were the main postoperative complications.
Implantation of prosthetic iris device combined with an intraocular lens appears to be safe and effective in reducing glare disability and improving visual acuity. Close, long-term monitoring is essential for the success of this surgery.
评估巩膜缝合人工虹膜人工晶状体治疗外伤性无晶状体眼和无虹膜症的长期疗效。
本单中心回顾性研究纳入了2008年6月至2016年2月在法国里昂爱德华·埃里奥医院接受莫尔彻组合植入物的所有连续病例。评估视力、主观眩光程度、生活质量和手术并发症。
纳入17例患者的17只眼,其中82%为男性。平均年龄42岁。损伤包括23.5%的挫伤和70.5%的开放性眼球损伤,其中41%为眼球破裂。有1例术后病例。8只眼同时进行了穿透性角膜移植术。平均随访32个月。41.2%的病例最佳矫正视力提高,17.6%保持不变,41.2%下降。术前视力可量化时,远视力平均提高1±0.25行,近视力提高2.2±0.32行。80%的患者眩光改善,20%保持稳定,平均从术前的3.3/5[最小值3 - 最大值4;标准差:0.48]降至术后的1.9/5[最小值0 - 最大值4;标准差:1.197]。关于美学效果,78%的患者表示相当满意至非常满意;57%的患者报告日常生活活动无限制,43%的患者报告有轻度限制。40%的眼出现高眼压和青光眼,是主要的术后并发症。
植入人工虹膜装置联合人工晶状体在减少眩光障碍和提高视力方面似乎是安全有效的。密切的长期监测对于该手术的成功至关重要。